1. Gonzalez JG, Elizondo G, Saldivar D, et al: Pituitary gland growth during normal pregnancy: an in vivo study using magnetic resonance imaging. Am J Med 85: 217, 1988.
2. Miki Y, Asato R, Okumura R, et al: Anterior pituitary gland in pregnancy: hyperintensity at MR. Radiology 187: 229, 1993.
3. Goluboff LG, Ezrin C: Effect of pregnancy on the somatotroph and the prolactin cell of the human adenohypophysis. J Clin Endocrinol Metab 29: 1533, 1969.
4. Scheithauer BW, Sano T, Kovacs KT, et al: The pituitary gland in pregnancy: a clinicopathologic and immunohistochemical study of 69 cases. Mayo Clin Proc 65: 461, 1990.
5. Stefaneanu L, Powell-Braxton L, Won W, Chandrashekar V, Bartke A: Somatotroph and lactotroph changes in the adenohypophyses of mice with disrupted insulin-like growth factor I gene. Endocrinology 140: 3881, 1999.
6. Vician L, Shupnik MA, Gorski J: Effects of estrogen on primary ovine pituitary cell cultures: stimulation of prolactin secretion, synthesis, and preprolactin messenger ribonucleic acid activity. Endocrinology 104: 736, 1979.
7. Maurer RA: Relationship between estradiol, ergocryptine, and thyroid hormone: effects on prolactin synthesis and prolactin messenger ribonucleic acid levels. Endocrinology 110: 1515, 1982.
8. Rakoff JS, Yen SSC: Progesterone induced acute release of prolactin in estrogen primed ovariectomized women. J Clin Endocrinol Metab 47: 918, 1978.
9. Rigg LA, Lein A, Yen SSC: Pattern on increase in circulating prolactin levels during human gestation. Am J Obstet Gynecol 129: 454, 1977.
10. Frankenne F, Closset J, Gomez F, et al: The physiology of growth hormones (GHs) in pregnant women and partial characterization of the placental GH variant. J Clin Endocrinol Metab 66: 1171, 1988.
11. Eriksson L, Frankenne F, Eden S, et al: Growth hormone 24-h serum profiles during pregnancy-lack of pulsatility for the secretion of the placental variant. Br J Obstet Gynaecol 106: 949, 1989.
12. Goodman HM, Tai L-R, Ray J, et al: Human growth hormone variant produces insulin-like and lipolytic responses in rat adipose tissue. Endocrinology 129: 1779, 1991.
13. MacLeod JN, Worsley I, Ray J, et al: Human growth hormone-variant is a biologically active somatogen an lactogen. Endocrinology 128: 1298, 1991.
14. Caufriez A, Frankenne F, Enlert Y, et al: Placental growth hormone as a potential regulator of maternal IGF-1 during human pregnancy. Am J Physiol 258: E1014, 1990.
15. Glinoer D, de Nayer P, Bourdoux P, et al: Regulation of maternal thyroid during pregnancy. J Clin Endocrinol Metab 71: 276, 1990.
16. Kotarba DD, Garner PR, Perkins S: Changes in serum free thyroxine, free tri-iodothyronine, and thyroid stimulating hormone reference intervals in normal term pregnant women. J Obstet Gynecol 15: 5, 1995.
17. Jeppsson S, Rannevik G, Liedholm P, et al: Basal and LHRH stimulated secretion of FSH during pregnancy. Am J Obstet Gynecol 127: 32, 1977.
18. Kredentser JV, Hoskins CF, Scott JZ: Hyperprolactinemia: a significant factor in female infertility. Am J Obstet Gynecol 139: 264, 1981.
19. Molitch ME: Disorders of prolactin secretion. Endocrinol Metab Clin N Amer. 30:585-610, 2001.
20. Webster J, Piscitelli G, Polli A, et al: A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. N Engl J Med 331: 904, 1994.
21. Biller BMK, Molitch ME, Vance ML, et al: Treatment of prolactin-secreting macroadenomas with the once-weekly dopamine agonist cabergoline. J Clin Endocrinol Metab 81: 2338, 1996.
22. Verhelst J, Abs R, Maiter D, et al: Cabergoline in the treatment of hyperprolactinemia. J Clin Endocrinol Metab 84: 2518, 1999.
23. Molitch ME. Management of prolactinomas during pregnancy. J Reprod Med 44: 1121, 1999.
24. Bigazzi M, Ronga R, Lancranjan I, et al: A pregnancy in an acromegalic woman during bromocriptine treatment: effects on growth hormone and prolactin in the maternal, fetal, and amniotic compartments. J Clin Endocrinol Metab 48: 9, 1979.
25. Krupp P, Monka C, Richter K. The safety aspects of infertility treatments. In: Program of the Second World Congress of Gynecology and Obstetrics, Rio de Janeiro, Brazil, 9, 1988.
26. Robert E, Musatti L, Piscitelli G, Ferrari CI: Pregnancy outcome after treatment with the ergot derivative, cabergoline. Reprod Toxicol 10: 333, 1996.
27. Divers WA, Yen SSC: Prolactin-producing microadenomas in pregnancy. Obstet Gynecol 62: 425, 1983.
28. Corenblum B, Donovan L: The safety of physiological estrogen plus progestin replacement therapy and with oral contraceptive therapy in women with pathological hyperprolactinemia. Fertil Steril 59: 671, 1993.
29. Jadresic A, Banks LM, Child DF, et al: The acromegaly syndrome: relation between clinical features, growth hormone values and radiological characteristics of the pituitary tumors. Q J Med 51: 189, 1982.
30. Molitch ME: Clinical manifestations of acromegaly. Endocrinol Metab Clin North Am 21: 597, 1992.
31. Nagamani M, Lingold JC, Gomez LG: Hyperthecosis of the ovaries in acromegaly. Obstet Gynecol 56: 258, 1980.
32. Advis JP, White SS, Ojeda SR: Activation of growth hormone short loop negative feedback delays puberty in the female rat. Endocrinololgy 108: 1343, 1981.
33. Hsu CJ, Hammond JM: Concomitant effects of growth hormone on secretion of insulin-like growth factor I and progesterone by cultured porcine granulosa cells. Endocrinology 121: 1343, 1987.
34. Beckers A, Stevenaert A, Foidart J-M, et al: Placental and pituitary growth hormone secretion during pregnancy in acromegalic women. J Clin Endocrinol Metab 71: 725,1990.
35. Barkan AL, Stred SE, Reno K, et al: Increased growth hormone pulse frequency in acromegaly. J Clin Endocrinol Metab 69: 1225, 1989.
36. Wilson DM, Bennett A, Adamson GD, et al: Somatomedins in pregnancy: a cross-sectional study of insulin-like growth factors I and II and somatomedin peptide content in normal human pregnancies. J Clin Endocrinol Metab 55: 858, 1982.
37. Herman-Bonert V, Seliverstov M, Melmed S: Pregnancy outcome in acromegaly: successful therapeutic outcome. J Clin Endocrinol Metab 83: 727, 1998.
38. Kupersmith MJ, Rosenberg C, Kleinberg D: Visual loss in pregnant women with pituitary adenomas. Ann Intern Med 121: 473, 1994.
39. Okada Y, Morimoto I, Ejima K, et al: A case of active acromegalic woman with a marked increase in serum insulin-like growth factor-1 levels after delivery. Endocr J 44: 117, 1997.
40. Colao A, Merola B, Ferone D, Lombardi G: Acromegaly. J Clin Endocrinol Metab 82: 2777, 1997.
41. Takeuchi K, Funakoshi T, Oomori S, Maruo T: Successful pregnancy in an acromegalic woman treated with octreotide. Obstet Gynecol 93: 848, 1999.
42. Fassnacht M, Capeller B, Arlt W, et al: Octreotide LAR treatment throughout pregnancy in an acromegalic woman. Clin Endocrinol 55: 411, 2001.
43. De Menis E, Billeci D, Marton E: Uneventful pregnancy in an acromegalic patient treated with slow-release lanreotide: a case report. J Clin Endocrinol Metab 84: 1489, 1999.
44. . Sanchez R, Boix E, delPino Navarro M, Pico A: Pregnancy in an acromegalic patient treated with lanreotide and bromocryptin. Medicina Clinica 113: 198, 1999.
45. Caron P, Gerbeau C, Pradayrol L, et al: Successful pregnancy in an
infertile woman with a thyrotropin-secreting macroadenoma treated with
somatostatin analog (octreotide). J Clin Endocrinol Metab 81: 1164, 1996.
46. Caron P, Bennet A, Lorenzini F, et al: Normal pregnancy in a woman with nesidioblastosis treated with somatostatin analog octreotide. Prog 81st Annual Meeting of the Endocrine Society, San Diego, 1999.
47. Sheehan HL, Davis JC: Pituitary necrosis. Br Med Bull 24: 59, 1968.
48. Ozbey N, Inanc S, Aral F, et al: Clinical and laboratory evaluation of 40 patients with Sheehan's syndrome. Isr J Med Sci 30: 826, 1994.
49. Sheehan HL: The neurohypophysis in post-partum hypopituitarism. J Pathol Bacteriol 85: 145, 1963.
50. Iwasaki Y, Oiso Y, Yamauchi K, et al: Neurohypophyseal function in post-partum hypopituitarism: impaired plasma vasopressin response to osmotic stimuli. J Clin Endocrinol Metab 68: 560, 1989.
51. Bakiri F, Bendib S-E, Maoui R, et al: The sella turcica in Sheehan's syndrome: computerized tomographic study in 54 patients. J Endocrinol Invest 14: 193, 1991.
52. Pressman EK, Zeidman SM, Reddy UM, et al: Differentiating lymphocytic adenohypophysitis from pituitary adenoma in the peripartum patient. J Reprod Med 40: 251, 1995.
53. Thodou E, Asa SL, Kontogeorgos G, et al: Lymphocytic hypophysitis: clinicopathological findings. J Clin Endocrinol Metab 80: 2302, 1995.
54. Gillam M, Molitch ME: Lymphocytic hypophysitis. In Pituitary Tumors in Pregnancy. Bronstein MD (ed. ). Kluwer Academic Publishers. Norwell, MA. 2001, pp. 131-148.
55. Lindheimer MD, Davison JM: Osmoregulation, the secretion of arginine vasopressin and its metabolism during pregnancy. Eur J Endocrinol 132: 133, 1995.
56. Davison JM, Shiells EA, Barron WM, et al: Changes in the metabolic clearance of vasopressin and of plasma vasopressinase throughout human pregnancy. J Clin Invest 83: 1313, 1989.
57. Barron WM: Water metabolism and vasopressin secretion during pregnancy. Baillieres Clin Obstet Gynaecol 1: 853, 1987.
58. Durr JA: Diabetes insipidus in pregnancy. Am J Kidney Dis 9: 276, 1987.
59. Dawood MY, Ylikorkala O, Trivedi D, et al: Oxytocin in maternal circulation and amniotic fluid during pregnancy. J Clin Endocrinol Metab 49: 429, 1979.
60. Gibbens GLD, Chard T: Observations on maternal oxytocin release during human labor. Am J Obstet Gynecol 126: 243, 1976.
61. Dawood MY, Khan-Dawood FS, Wahi R, et al: Oxytocin release and plasma anterior pituitary and gonadal hormones in women during lactation. J Clin Endocrinol Metab 52: 678, 1981.
62. Soule SG, Monson JP, Jacobs HS: Transient diabetes insipidus in pregnancy-a consequence of enhanced placental clearance of arginine vasopressin. Hum Reprod 10: 3322, 1995.
63. Iwasaki Y, Oiso Y, Kondo K, et al: Aggravation of subclinical diabetes insipidus during pregnancy. N Engl J Med 324: 522, 1991.
64. Barron WM, Cohen LH, Ulland LA, et al: Transient vasopressin-resistant diabetes insipidus of pregnancy. N Engl J Med 310: 442, 1984.
65. Kaellen BAJ, Carlsson SS, Bengtsson BKA: Diabetes insipidus and use of desmopressin (Minirin) during pregnancy. Eur J Endocrinol 132: 144, 1995.
66. Ray JG: DDAVP use during pregnancy: an analysis of its safety for mother and child. Obstet Gynecolol Survey 53: 450, 1998.
67. Kennedy S, Hall PM, Seymour AE, Hague WM: Transient diabetes insipidus and acute fatty liver of pregnancy. Br J Obstet Gynaecol 101: 387, 1994.
68. Krege J, Katz VL, Bowes Jr WA: Transient diabetes insipidus of pregnancy. Obstet Gynecolol Survey 44: 789, 1989.
69. Raziel A, Rosenberg T, Schreyer P, et al: Transient postpartum diabetes insipidus. Am J Obstet Gynecol 164: 616, 1991.
70. Hawker RW, North WG, Colbert IC, Lang LP: Oxytocin blood levels in two cases of diabetes insipidus. Br J Obstet Gynaecol 74: 430, 1987.
71. Glinoer D: The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev 18: 404, 1997.
72. Hollowell JG, Staehling NW, Hannon WH, et al: Iodine nutrition in the United States. Trends and public health implications: Iodine excretion data from National Health and Nutrition Examination Surveys I and III (1971-1974 and 1988-1994). J Clin Endocrinol Metab 83: 3401, 1998.
73. Dunn JT, Delange F: Damaged reproduction: the most important consequence of iodine deficiency. J Clin Endocrinol Metab 86: 2360, 2001.
74. Momotani N, Hisaoka T, Noh J, et al. Effects of iodine on thyroid status of fetus versus mother in treatment of Graves disease complicated by pregnancy. J Clin Endocrinol Metab 75:738, 1992.
75. Glinoer D, De Nayer P, Delange F, et al: A randomized trial for the treatment of mild iodine deficiency during pregnancy: Maternal and neonatal effects. J Clin Endocrinol Metab 80: 258, 1995.
76. Klett M, Ohlig M, Manz F, Troeger J, Heinrich U: Effect of iodine supply on neonatal thyroid volume and TSH. Acta Paediatr Suppl 432: 18, 1999.
77. Nohr SB, Laurberg P: Opposite variations in maternal and neonatal thyroid function induced by iodine supplementation during pregnancy. J Clin Endocrinol Metab 85: 623, 2000.
78. Weber G, Vigone MC, Rapa A, et al: Neonatal transient hypothyroidism: aetiological study. Arch Dis Child Fetal Neonatal Ed 79: F70, 1998.
79. Danziger Y, Pertzelan A, Mimouni M: Transient congenital hypothyroidism after topical iodine in pregnancy and lactation. Arch Dis Child 62: 295, 1987.
80. Brown RS, Bloomfield S, Bednarek FJ, Mitchell ML, Braverman LE: Routine skin cleansing with povidone-iodine is not a common cause of transient neonatal hypothyroidism in North America: a prospective controlled study. Thyroid 7: 395, 1997.
81. Alexander WD, Koutras DA, Crooks J, et al: Quantitative studies of iodine metabolism in thyroid disease. QJM 31: 281, 1972.
82. Smyth PPA, Hetherton MT, Smith DR, et al: Maternal iodine states and thyroid volume during pregnancy: correlation with neonatal iodine intake. J Clin Endocrinol Metab 82: 2840, 1997.
83. Levy RP, Newman DM, Rejai LS, et al. The myth of goiter in pregnancy. Am J Obstet Gynecol 137:701, 1980.
84. Long TJ, Felice ME, Hollingsworth DR. Goiter in pregnant teenagers. Am J Obstet Gynecol 152:670, 1985.
85. Glinoer D, Soto MF, Bourdoux P, et al: Pregnancy in patients with mild thyroid abnormalities: maternal and neonatal repercussions. J Clin Endocrinol Metab 73: 421, 1991.
86. Yoshimura M, Hershman JM: Thyrotropic action of human chorionic gonadotropin. Thyroid 5: 425, 1995.
87. Goodwin TM, Hershman JM: Hyperthyroidism due to inappropriate production of human chorionic gonadotropin. Clin Obstet Gynecol 40:32, 1997.
88. Pekonen F, Alfthan H, Stenman U-H, Ylikorkala O: Human chorionic gonadotropin (hCG) and thyroid function in early human pregnancy: circadian variation and evidence for intrinsic thyrotropic activity of hCG. J Clin Endocrinol Metab 66: 853, 1988.
89. Glinoer D, De Nayer P, Robyn C, Lejeune B, Kinthaert J, Meuris S: Serum levels of intact human chorionic gonadotropin (hCG) and its free a and b subunits, in relation to maternal thyroid stimulation during normal pregnancy. J Endocrinol Invest 16: 881, 1993.
90. Ginsberg J, Lewanczuk RZ, Honore LH: Hyperplacentosis: a novel cause of hyperthyroidism. Thyroid 11: 393, 2001.
91. Gruen JP, Meuris S, De Nayer P, Glinoer D: The thyrotropic role of human chorionic gonadotropin (hCG) in the early stages of twin (vs. single) pregnancy. J Clin Endocrinol 46: 719, 1997.
92. Thodou E, Asa SL, Kontogeorgos G, et al. Lymphocytic hypophysitis: clinicopathological findings. J Clin Endocrinol Metab 80:2302, 1995.
93. Harada K, Hershman JM, Reed AW, et al. Comparison of thyroid stimulators and thyroid hormone concentrations in the sera of pregnant women. J Clin Endocrinol Metab 48:793, 1979.
94. Glinoer D, Delange F: The potential repercussions of maternal, fetal, and neonatal hypothyroxinemia on the progeny. Thyroid 10: 871, 2000.
95. Contempre B, Jauniaux E, Calvo R, Jurkovic D, Campbell S, Morreale de Escobar G: Detection of thyroid hormones in human embryonic cavities during the first trimester of gestation. J Clin Endocrinol Metab 77: 1719, 1993.
96. Bernal J, Pekonen F: Ontogenesis of the nuclear 3,5,3'-triiodothyronine receptor in the human fetal brain. Endocrinology 114: 677, 1984.
97. Thorpe-Beeston J, Nicolaides K, Felton C, et al: Maturation of the secretion of thyroid hormone and thyroid-stimulating hormone in the fetus. N Engl J Med 324: 531, 1991.
98. Nicolini U, Venegoni E, Acaia B, et al. Prenatal treatment of hypothyroidism: is there more than one option? Prenatal Diagnosis 16: 443, 1996.
99. Burrow G: Thyroid function and hyperfunction during gestation. Endocrinol Rev 14: 194, 1993.
100. Mestman JH: Hyperthyroidism in pregnancy. Clin Obstet Gynecol 40: 45, 1997.
101. Stagnaro-Green A, Roman SH, Cobin RH, el-Harazy E, Wallenstein S, Davies TF: A prospective study of lymphocyte-initiated immunosuppression in normal pregnancy: Evidence of a T-cell etiology for postpartum thyroid dysfunction. J Clin Endocrinol Metab 74: 645, 1992.
102. Sridama V, Pacini F, Yang SL, Moawad A, Reilly M, DeGroot LJ: Decreased levels of helper T cells: A possible cause of immunodeficiency in pregnancy. N Engl J Med 307: 352, 1982.
103. Millar LK, Wing DA, Leung AS, Koonings PP, Montoro MN, Mestman JH: Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol 84: 946, 1994.
104. Davis LE, Lucas MJ, Hankins GD, Roark ML, Cunningham FG: Thyrotoxicosis complicating pregnancy. Am J Obstet Gynecol 160: 63, 1989.
105. Marchant B, Brownlie BEW, Hart DM, et al. The placental transfer of propylthiouracil, methimazole and carbimazole. J Clin Endocrinol Metab 45:1187, 1977.
106. Mortimer RH, Cannell GR, Addison RS, Johnson LP, Roberts MS, Bernus I: Methimazole and propylthiouracil equally cross the perfused human term placental lobule. J Clin Endocrinol Metab 82: 3099, 1997.
107. Gardner DF, Cruikshank DP, Hays PM, Cooper DS: Pharmacology of propylthiouracil (PTU) in pregnant hyperthyroid women: correlation of maternal PTU concentrations with cord serum thyroid function tests. J Clin Endocrinol Metab 62: 217, 1986.
108. Mandel SJ, Cooper DS: The use of antithyroid drugs in pregnancy and lactation. J Clin Endocrinol Metab 86: 2354, 2001.
109. Martinez-Frias ML, Cereijo A, Rodriguez-Pinilla E, Urioste M: Methimazole in animal feed and congenital aplasia cutis. Lancet 339: 742, 1992.
110. Clementi M, Di Gianantonio E, Pelo E, Mammi I, Basile RT, Tenconi R: Methimazole embryopathy: delineation of the phenotype. Am J Med Genet 83: 43, 1999.
111. Johnsson E, Larsson G, Ljunggren M: Severe malformations in infant born to hyperthyroid woman on methimazole. Lancet 350: 1520, 1997.
112. Gardner DF, Cruikshank DP, Hays PM, Cooper DS: Pharmacology of propylthiouracil (PTU) in pregnant hyperthyroid women: Correlation of maternal PTU concentrations with cord serum thyroid function tests. J Clin Endocrinol Metab 62: 217, 1986.
113. Momotani N, Noh JY, Ishikawa N, Ito K: Effects of proprylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism. J Clin Endocrinol Metab 82: 3633, 1997.
114. Messer MP, Hauffa BP, Olbricht T, et al. Antithyroid drug and Graves' disease in pregnancy. Long term effects on somatic growth, intellectual development and thyroid function of the offspring. Acta Endocrinol 123: 311, 1990.
115. Kyle PM, Redman CW. Comparative risk-benefit assessment of drugs used in the management of hypertension in pregnancy. Drug Saf 7: 223, 1992.
116. Eriksson M, Rubenfeld S, Garber AJ, et al. Propranolol does not prevent thyroid storm. N Engl J Med 296: 263, 1977.
117. Senior B, Chernoff HL: Iodide goiter in the newborn. Pediatr 47: 510, 1971.
118. Utiger RD. Recognition of thyroid disease in the fetus. N Engl J Med 324: 550, 1991.
119. Linden S, Rich CL. The use of lithium during pregnancy and lactation. J Clin Psychiatry 44: 358, 1983.
120. Brodsky JB, Cohen EN, Brown BW, et al. Surgery during pregnancy and fetal outcome. Am J Obstet Gynecol 138:1165, 1980.
121. Marigold JH, Morgan AK, Earle DJ, Young AE, Croft DN: Lugol's iodine: its effect on thyroid blood flow in patients with thyrotoxicosis. Br J Surg 72: 45, 1985.
122. Marmon L, Au FC: The preoperative use of iodine solution in thyrotoxic patients prepared with propranolol. Is it necessary? Am Surg 55: 629, 1989.
123. Kaur S, Parr JH, Ramsay ID, Hennebry TM, Jarvis KJ, Lester E: Effect of preoperative iodine in patients with Graves' disease controlled with antithyroid drugs and thyroxine. Ann R Coll Surg Engl 70: 123, 1988.
124. Swaminathan R, Chin RK, Lao TTH, et al. Thyroid function in hyperemesis gravidarum. Acta Endocrinol (Copenh) 120: 155, 1989.
125. Goodwin TM, Montoro M, Mestman J. Transient hyperthyroidism and hyperemesis gravidarum: clinical aspects. Am J Obstet Gynecol 167: 648, 1992.
126. Bouillon R, Naesens M, Van Assche FA, et al: Thyroid function in patients with hyperemesis gravidarum. Am J Obstet Gynecol 143: 922, 1982.
127. Chin RK, Lao TT: Thyroxine concentrations and outcome of hyperemetic pregnancies. Br J Obstet Gynaecol 95: 507, 1988.
128. Goodwin TM, Montoro M, Mestman JH, Pekary AE, Hershman JM: The role of chorionic gonadotropin in transient hyperthyroidism of hyperemesis gravidarum. J Clin Endocrinol Metab 75: 1333, 1992.
129. Tsuruta E, Tada H, Tamaki H, et al: Pathogenic role of asial human chroionic gonadotropin in gestational thyrotoxicosis. J Clin Endocrinol Metab 80: 350, 1995.
130. Talbot JA, Lambert A, Anobile CJ, et al: The nature of human chorionic gonadotropin glycoforms in gestational thyrotoxicosis. Clin Endocrinol 55: 393, 2001.
131. Goodwin TM, Montoro M, Mestman JH: Transient hyperthyroidism and hyperemesis gravidarum: Clinical aspects. Am J Obstet Gynecol 167: 648, 1992.
132. Rodien P, Brémont C, Sanson M-LR, et al: Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin. N Engl J Med 339: 1823, 1998.
133. Hatjis CG. Diagnosis and successful treatment of fetal goitrous hyperthyroidism caused by maternal Graves disease. Obstet Gynecol 81: 837, 1993.
134. Kampmann JP, Johansen K, Hansen JM, Helweg J: Propylthiouracil in human milk: revision of a dogma. Lancet 1: 736, 1980.
135. Mamotani N, Yamashita R, Yoshimoto M, Noh J, Ishikawa N, Ito K: Recovery from foetal hypothyroidism: evidence for the safety of breast-feeding while taking propylthiouracil. Clin Endocrinol 31: 591, 1989.
136. Azizi F, Khoshniat M, Bahrainian M, Hedayati M: Thyroid function and intellectual development of infants nursed by mothers taking methimazole. J Clin Endocrinol Metab 85: 3233, 2000.
137. Cooper DS. Antithyroid drugs. To breast-feed or not to breast-feed. Am J Obstet Gynecol 157: 234, 1987.
138. Eskin BA, Parker JA, Bassett JG, George DL: Human breast uptake of radioactive iodine. Obstet Gynecol 44: 398, 1974.
139. Tazebay UH, Wapnir IL, Levy O, et al: The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med 6: 871, 2000.
140. Dydek GJ, Blue PW: Human breast milk excretion of iodine-131 following diagnostic and therapeutic administration to a lactating patient with Graves' disease. J Nucl Med 29: 407, 1988.
141. Rumble WF, Aamodt RL, Jones AE, et al. Case reports. Accidental ingestion of Tc-99m in breast milk by a 10-week old child. J Nucl Med 19: 913, 1978.
142. Doody RE, Becker DV, Brill AB, et al: Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group. JAMA 280: 347, 1998.
143. Klein R, Haddow J, Faix J, et al: Prevalence of thyroid deficiency in pregnant women. Clin Endocrinol 35: 41, 1991.
144. Soler NG, Nicholson H: Diabetes and thyroid disease during pregnancy. Obstet Gynecol 54: 318, 1979.
145. Grodstein F, Goldman MB, Ryan L, Cramer DW: Self reported use of pharmaceuticals and primary ovulatory infertility. Epidemiology 4: 151, 1993.
146. Leung AS, Millar LK, Koonings PP, et al. Perinatal outcome in hypothyroid pregnancies. Obstet Gynecol 81: 349, 1993.
147. Wasserstrum N, Anania CA: Perinatal consequences of maternal hypothyroidism in early pregnancy and inadequate replacement. Clin Endocrinol 42: 353, 1995.
148. Cooper DS, Saxe VC, Meskell M, Maloof F, Ridgway EC: Acute effects of propylthiouracil (PTU) on thyroidal iodide organification and peripheral iodothyronine deiodination: correlation with serum PTU levels measured by radioimmunoassay. J Clin Endocrinol Metab 54: 101, 1982.
149. Ahren B, Rerup C: Kinetics of radioiodine released from prelabelled thyroid gland in vivo: influence of propylthiouracil. Pharmacology & Toxicology 61: 69, 1987.
150. Turton DB, Silverman ED, Shakir KM: Time interval between last dose of propylthiouracil and I-131 therapy influences cure rates in hyperthyroidism caused by Graves' disease. Clin Nucl Med 23: 810, 1998.
151. Imseis RE, Vanmiddlesworth L, Massie JD, Bush AJ, Van Middlesworth NR: Pretreatment with propylthiouracil but not methimazole reduces the therapeutic efficacy of iodine-131 in hyperthyroidism. J Clin Endocrinol Metab 83: 685, 1998.
152. Hancock LD, Tuttle RM, LeMar H, Bauman J, Patience T: The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease. Clin Endocrinol 47: 425, 1997.
153. Smallridge RC, Ladenson PW: Hypothyroidism in pregnancy: consequences to neonatal health. J Clin Endocrinol Metab 86: 2349, 2001.
154. Haddow JE, Palomaki GE, Allan WC, et al: Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 341: 549, 1999.
155. Pop V, Kuipens JL, van Baar AL, et al: Low normal maternal free T4 concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol 50: 149, 1999.
156. Morreale de Escobar G, Obregon MJ, del Rey FE: Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia? J Clin Endocrinol Metab 85: 3975, 2000.
157. Mandel SJ, Larsen PR, Seely EW, Brent GA. Increased need for thyroxine during pregnancy in women with primary hypothyroidism. N Engl J Med 323: 91, 1990.
158. Campbell NRC, Hasinoff BB, Stalts H, et al. Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism. Ann Intern Med 117: 1010, 1992.
159. Singh N, Weisler SL, Hershman JM: The acute effect of calcium carbonate on the intestinal absorption of levothyroxine. Thyroid 11: 967, 2001.
160. Nikolai TF, Turney SL, Roberts RC. Postpartum lymphocytic thyroiditis. Prevalence, clinical course, and long-term follow-up. Arch Intern Med 147: 221, 1987.
161. Lazarus JH, Hall R, Rothman S, et al. The clinical spectrum of postpartum thyroid disease. Q J Med 89: 429, 1996.
162. Terry AJ, Hague WM: Postpartum thyroiditis. Sem Perinatol 22:497, 1998.
163. Gerstein HC: Incidence of postpartum thyroid dysfunction in patients with Type I diabetes mellitus. Ann Intern Med 118: 419, 1993.
164. Lazarus JH: Prediction of postpartum thyroiditis. Eur J Endocrinol 139: 12, 1998.
165. Muller AF, Drexhage HA, Berghout A: Postpartum thyroiditis and autommune thyroiditis in women of childbearing age: recent insights and consequences for antenatal and postnatal care. Endocr Rev 22: 605, 2001.
166. Caixas A, Albareda M, Garcia-Patterson A, Rodriguez-Espinosa J, deLeiva A, Corcoy R: Postpartum thyroiditis in women with hypothyroidism antedating pregnancy? J Clin Endocrinol Metab 84: 4000, 1999.
167. Roti E, Minelli R, Gardini E, et al. Impaired intrathyroidal iodine organification and iodine-induced hypothyroidism in euthyroid women with a previous episode of postpartum thyroiditis. J Clin Endocrinol Metab 73: 958, 1991.
168. Premawardhana LDKE, Lazarus JH, Adams H, Parkes AB: Abnormalities of thyroid function and morphology 7-10 years after postpartum thyroid dysfunction [PPTD]. J Endocrinol Invest 19: 74, 1996.
169. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC: Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 132: 270, 2000.
170. Struve CW, Haupt S, Ohlen S: Influence of frequency of previous pregnancies on the prevalence of thyroid nodules in women without clinical evidence of thyroid disease. Thyroid 3: 7, 1993.
171. Molitch ME, Beck JR, Dreisman M, et al. The cold thyroid nodule. An analysis of diagnostic and therapeutic options. Endocr Rev 5: 185, 1984.
172. McTiernan AM, Weiss NS, Daling JR: Incidence of thyroid cancer in women in relation to reproductive and hormonal factors. Am J Epidemiol 120: 423, 1984.
173. Akslen LA, Nilssen S, Kva'le G: Reproductive factors and risk of thyroid cancer: A prospective study of 63,090 women from Norway. Br J Cancer 65: 772, 1992.
174. Herzon FS, Morris DM, Segal MN, Rauch G, Parnell T: Coexistent thyroid cancer and pregnancy. Arch Otolaryngol Head Neck Surg 120: 1191, 1994.
175. Mestman JH, Goodwin M, Montoro MM: Thyroid disorders of pregnancy. Endocrinol Metab Clin North Am 24: 41, 1995.
176. Rosen IB, Walfish PG: Pregnancy as a predisposing factor in thyroid neoplasia. Arch Surg 121: 1287, 1986.
177. Rosen IB, Walfish PG, Nikore V: Pregnancy and surgical thyroid disease. Surgery 98: 1135, 1985.
178. Hay I: Nodular thyroid disease diagnosed during pregnancy: How and when to treat. Thyroid 9: 667, 1999.
179. Kobayashi K, Tanaka Y, Ishiguro S, Mori T: Rapidly growing thyroid carcinoma during pregnancy. J Surg Oncol 55: 61, 1994.
180. Herzon FS, Morris DM, Segal MN, et al. Coexistent thyroid cancer and pregnancy. Arch Otolaryngol Head Neck Surg 120: 1191, 1994.
181. Kovacs CS: Calcium and bone metabolism in pregnancy and lactation. J Clin Endocrinol Metab 86: 2344, 2001.
182. Mestman JH: Parathyroid disorders of pregnancy. Sem Perinatol 22: 485, 1998.
183. Rasmussen N, Rolich A, Hornnes PJ, Hegedus L. Serum ionized calcium and intact parathyroid hormone levels during pregnancy and postpartum. Br J Obstet Gynaecol 97: 857, 1990.
184. Dahlman T, Sjoberg HE, Bucht E: Calcium homeostasis in normal pregnancy and puerperium. A longitudinal study. Acta Obstet Gynecol Scand 73: 393, 1994.
185. Saggese G, Baroncelli GI, Bertelloni S, Cipolloni C: Intact parathyroid hormone levels during pregnancy, in healthy term neonates and in hypocalcemic preterm infants. Acta Paediatr Scand 80: 36, 1991.
186. Seely EW, Brown EM, DeMaggio DM, Weldon DK, Graves SW: A prospective
study of calciotropic hormones in pregnancy and post partum: reciprocal changes
in serum intact parathyroid hormone and 1,25-dihydroxyvitamin D. Am J Obstet
Gynecol 176: 214, 1997.
187. Cross NA, Hillman LS, Allen SH, Krause GF, Vieira NE: Calcium homeostasis and bone metabolism during pregnancy, lactation, and postweaning: a longitudinal study. Am J Clin Nutr 61: 514, 1995.
188. Wieland P, Fischer JA, Trechsel U, et al: Perinatal parathyroid hormone, vitamin D metabolites, and calcitonin in man. Am J Physiol 239: E385, 1980.
189. Kovacs CS, Kronenberg HM: Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation. Endocr Rev 18: 832, 1997.
190. Gallacher SJ, Fraseer WD, Owens OJ, et al: Changes in calciotrophic hormones and biochemical markers of bone turnover in normal human pregnancy. Eur J Endocrinol 131: 369, 1994.
191. Bertelloni S, Baroncelli GI, Pelletti A, Battini R, Saggese G: Parathyroid hormone-related protein in healthy pregnant women. Calcif Tissue Int 54: 195, 1994.
192. Ferguson II JE, Gorman JV, Bruns DE, et al: Abundant expression of parathyroid hormone-related protein in human amnion and its association with labor. Proc Natl Acad Sci USA 89: 8384, 1992.
193. Purdie DW, Aaron JE, Selby PL: Bone histology and mineral homeostasis in human pregnancy. Br J Obstet Gynaecol 95: 849, 1988.
194. Gambacciani M, Spinetti A, Gallo R, Cappagli B, Teti GC, Facchini V: Ultrasonographic bone characteristics during normal pregnancy: longitudinal and cross-sectional evaluation. Am J Obstet Gynecol 173: 890, 1995.
195. Yamaga A, Taga M, Minaguchi H, Sato K: Changes in bone mass as determined by ultrasound and biochemical markers of bone turnover during pregnancy and puerperium: a longitudinal study. J Clin Endocrinol Metab 81: 752, 1996.
196. Sowers M: Pregnancy and lactation as risk factors for subsequent bone loss and osteoporosis. J Bone Miner Res 11: 1052, 1996.
197. Salem R, Taylor S. Hyperparathyroidism in pregnancy. Br J Surg 66: 648, 1979.
198. Shangold MM, Dor N, Welt SL, et al. Hyperparathyroidism and pregnancy. A review. Obstet Gynecol Surv 37: 217, 1982.
199. Mansberger JA, Mansberger AR Jr. Hyperparathyroidism and pregnancy. Case report and therapy update. J Med Assoc Ga 77: 309, 1988.
200. Rude RK, Haussler MR, Singer FR: Postpartum resolution of hypocalcemia in a lactating hypoparathyroid patient. Endocrinol Jpn 31: 227, 1984.
201. Cundy T, Haining SA, Guilland-Cumming DF, Butler J, Kanis JA: Remission of hypoparathyrodism during lactation: evidence for a physiological role for prolactin in the regulation of vitamin D metabolism. Clin Endocrinol 26: 667, 1987.
202. Aceto T Jr, Batt RE, Bruck E, et al. Intrauterine hyperparathyroidism: a complication of untreated maternal hypoparathyroidism. J Clin Endocrinol Metab 26: 487, 1966.
203. Dobnig H, Kainer F, Stepan V, et al: Elevated parathyroid hormone-related peptide levels after human gestation: relationship to changes in bone and mineral metabolism. J Clin Endocrinol Metab 80: 3699, 1995.
204. Lippuner K, Zehnder HJ, Casez JP, Takkinen R, Jaeger P: Effects of PTH-related protein (PTH-rP) on calcium-phosphate metabolism in nursing mothers. Bone 16(Suppl1): 209S, 1995.
205. Khosla S, Johansen KL, Ory SJ, O'Brien PC, Kao PC: Parathyroid hormone-related peptide in lactation and in umbilical cord blood. Mayo Clin Proc 65: 1408, 1990.
206. Budayr AA, Halloran BP, King JC, Diep D, Nissenson RA, Strewler GJ: High levels of a parathyroid hormone-like protein in milk. Proc Natl Acad Sci USA 86: 7183, 1989.
207. Sowers MF, Hollis BW, Shapiro B, et al: Elevated parathyroid homone-related peptide associated with lactation and bone density loss. J Am Med Assoc 276: 549, 1996.
208. Laskey MA, Prentice A, Hanratty LA, et al: Bone changes after 3 mo of lactation: influence of calcium intake, breast-milk output, and vitamin D receptor genotype. Am J Clin Nutr 67: 685, 1998.
209. Cross NA, Hillman LS, Allen SH, Krause GF: Changes in bone mineral density and markers of bone remodeling during lactation and postweaning in women consuming high amounts of calcium. J Bone Miner Res 10: 1312, 1995.
210. Kalkwarf HJ, Specker BL, Bianchi DC, Ranz J, Ho M: The effect of calcium supplementation on bone density during lactation and after weaning. N Engl J Med 337: 523, 1997.
211. Polatti F, Capuzzo E, Viazzo F, Colleoni R, Klersy C: Bone mineral changes during and after lactation. Obstet Gynecol 94: 52, 1999.
212. Kolthoff N, Eiken P, Kristensen B, Nielsen SP: Bone mineral changes during pregnancy and lactation: a longitudinal cohort study. Clin Sci 94: 405, 1998.
213. Kovacs CS, Chik CL: Hyperprolactinemia caused by lactation and pituitary adenomas is associated with altered serum calcium, phosphate, parathyroid hormone (PTH), and PTH-related peptide levels. J Clin Endocrinol Metab 80: 3036, 1995.
214. Specker BL, Tsang RC, Ho ML: Changes in calcium homeostasis over the first year postpartum: effect of lactation and weaning. Obstet Gynecol 78: 56, 1991.
215. McLean M, Smith R: Corticotropin-releasing hormone in human pregnancy and parturition. Trends in Endocrinol Metab 10: 174, 1999.
216. Goland RS, Wardlaw SL, Stark RE, et al: High levels of
corticotropin-releasing
hormone immunoactivity in maternal and fetal plasma during pregnancy. J Clin
Endocrinol Metab 63: 1199, 1986.
217. Demey-Ponsart E, Foidart JM, Sulon J, et al: Serum CBG, free and total cortisol and circadian patterns of adrenal function in normal pregnancy. J Steroid Biochem 16: 165, 1982.
218. Dorr HG, Heller A, Versmold HT, et al: Longitudinal study of progestins, mineralocorticoids, and glucocorticoids throughout human pregnancy. J Clin Endocrinol Metab 68: 863, 1989.
219. Whiteley HJ, Stoner HB: The effect of pregnancy on the adrenal cortex. J Endocrinol 14: 325, 1957.
220. Rosenthal HE, Slaunwhite WR, Sandberg AA: Transcortin, a corticosteroid-binding protein of plasma: Cortisol and progesterone interplay and unbound levels of these steroids in pregnancy. J Clin Endocrinol Metab 29: 352, 1969.
221. Wilson M, Morganti AA, Zervoudakis I, et al: Blood pressure, the renin-aldosterone system and sex steroids throughout normal pregnancy. Am J Med 8: 97, 1980.
222. Ehrlich EN, Lindheimer MD: Effect of administered mineralocorticoids or ACTH in pregnant women. Attenuation of kaliuretic influence of mineralocorticoids during pregnancy. J Clin Invest 51: 1301, 1972.
223. Jones KM, Lloyd-Jones R, Riondel A, et al: Aldosterone secretion and metabolism in normal men and women and in pregnancy. Acta Endocrinol 30: 321, 1959.
224. Biglieri EG, Slaton, Jr, PE: Pregnancy and primary aldosteronism. J Clin Endocrinol Metab 27: 1628, 1967.
225. Bevan JS, Gough MH, Gillmer MDG, et al. Cushings syndrome in pregnancy. The timing of definitive treatment. Clin Endocrinol (Oxf) 27: 225, 1987.
226. Casson IF, Davis JC, Jeffreys RV, et al. Successful management of Cushings disease during pregnancy by transsphenoidal adenectomy. Clin Endocrinol (Oxf) 27: 423, 1987.
227. Aron DC, Schnall AM, Sheeler LR. Cushings syndrome and pregnancy. Am J Obstet Gynecol 162: 244, 1990.
228. Buescher MA, McClamrock HD, Adashi EY. Cushings syndrome in pregnancy. Obstet Gynecol 79: 130, 1992.
229. Ross RJ, Chew SL, Perry L, et al. Diagnosis and selective cure of Cushing's disease during pregnancy by transsphenoidal surgery. Europ J Endocrinol 132: 722, 1995.
230. Chico A, Manzanares JM, Halperin I, et al. Cushing's disease and pregnancy. Eur J Obstet Gynecol Reprod Biol 64: 143, 1996.
231. Guilhaume B, Sanson ML, Billaud L, et al. Cushing's syndrome and pregnancy: aetiologies and prognosis in twenty-two patients. Eur J Med 1: 83, 1992.
232. Wallace C, Toth EL, Lewanczuk RZ, Siminoski K: Pregnancy-induced Cushing's syndrome in multiple pregnancies. J Clin Endocrinol Metab 81: 15, 1996.
233. Kasperlik-Zaluska AA, Szczupacka I, Leszczynska-Bystrzanowska J, Drus-Przybyszewska G: Pregnancy-dependent Cushing's syndrome in three pregnancies. Br J Obstet Gynaecol 107: 810, 2000.
234. Nolten WE, Lindheimer MD, Rueckert PA, et al. Diurnal patterns and regulation of cortisol secretion in pregnancy. J Clin Endocrinol Metab 51: 466, 1980.
235. Pinette MG, Pan YQ, Oppenheim D, et al. Bilateral inferior petrosal sinus corticotropin sampling with corticotropin-releasing hormone stimulation in a pregnant patient with Cushing's syndrome. Am J Obstet Gynecol 171: 563, 1994.
236. Kreines K, DeVaux WD. Neonatal adrenal insufficiency associated with maternal Cushings syndrome. Pediatrics 47: 516, 1971.
237. Albert E, Dalaker K, Jorde R, Berge LN: Addison's disease and pregnancy. Acta Obstet Gynecol Scand 68:185, 1989.
238. Drucker D, Shumak S, Angel A. Schmidt's syndrome presenting with intrauterine growth retardation and postpartum Addisonian crisis. Am J Obstet Gynecol 149: 229, 1984.
239. Gamlen TR, Aynsley-Green A, Irvine WJ, McCallum CJ: Immunological studies in the neonate of a mother with Addison's disease and diabetes mellitus. Clin Exp Immunol 28: 192, 1977.
240. Osler M: Addison's disease and pregnancy. Acta Endocrinol 41: 67, 1962.
241. Normington EM, Davies D: Hypertension and oedema complicating pregnancy in Addison's disease. BMJ 1: 148, 1972.
242. Schlaghecke R, Kornely E, Santen RT, Ridderskamp P. The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone. N Engl J Med 326: 226, 1992.
243. Turner ES, Greenberger PA, Patterson R. Management of the pregnant asthmatic patient. Ann Intern Med 93: 905, 1980.
244. Beitins R, Baynard F, Ances IG, et al: The transplacental passage of prednisone and prednisolone in pregnancy near term. J Pediatr 81: 936, 1972.
245. Kream J, Mulay S, Fukushima DK, et al: Determination of plasma dexamethasone in the mother and the newborn after administration of the hormone in a clinical trial. J Clin Endocrinol Metab 56: 127, 1983.
246. Kenny FM, Preeyasombat C, Spaulding JS, et al. Cortisol production rate. IV. Infants born of steroid-treated mothers and of diabetic mothers. Infants with trisomy syndrome and with anencephaly. Pediatrics 37: 960, 1966.
247. Garner PR: Congenital adrenal hyperplasia in pregnancy. Sem Perinatol 22:446, 1998.
248. White PC, Speiser PW: Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 21: 245, 2000.
249. New MI, Carlson A, Obeid J, et al: Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies. J Clin Endocrinol Metab 86: 5651, 2001.
250. Premawardhana LDKE, Hughes IA, Read GF, Scanlon MF: Longer term outcome in females with congenital adrenal hyperplasia (CAH): the Cardiff experience. Clin Endocrinol 46: 327, 1997.
251. Feldman S, Billaud L, Thalabard J-C, et al: Fertility in women with late onset adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 74: 635, 1992.
252. Klingensmith GJ, Garcia SC, Jones HW, et al: Glucocorticoid treatment of girls with congenital adrenal hyperplasia: effect of height, sexual maturity, and fertility. J Pediatr 90: 996, 1977.
253. Krone N, Wachter I, Stafanidou M, Roscher AA, Schwarz HP: Mothers with congenital adrenal hyperplasia and their children: outcome of pregnancy, birth and childhood. Clin Endocrinol 55: 523, 2001.
254. New MI, Lorenzen F, Lerner AJ, et al: Genotyping sterioid 21-hydroxylase deficiency: hormonal reference data. J Clin Endocrinol Metab 57: 320, 1983.
255. Azziz R, DeWailly D, Owerbach D. Nonclassic adrenal hyperplasia: current concepts. J Clin Endocrinol Metab 78: 810, 1994.
256. Pang A, Pollack MS, Marshall RN, Immken LD. Prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl J Med 322: 111, 1990.
257. Pang S, Clark AT, Freeman LC, et al. Maternal side effects of prenatal dexamethasone therapy for fetal congenital adrenal hyperplasia. J Clin Endocrinol Metab 75: 249, 1992.
258. Baron F, Sprauve ME, Huddleston JF, Fisher AJ: Diagnosis and surgical treatment of primary aldosteronism in pregnancy: a case report. Obstet Gynecol 86: 644, 1995.
259. Solomon CG, Thiet M-P, Moore F Jr, Seely EW: Primary hyperaldosteronism in pregnancy. A case report. J Reprod Med 41: 255, 1996.
260. Webb JC, Bayliss P: Pregnancy complicated by primary hyperaldosteronism. Southern Med J 90: 243, 1997.
261. Robar CA, Poremba JA, Pelton JJ, et al. Current diagnosis and management of aldosterone-producing adenomas during pregnancy. The Endocrinologist 8: 403, 1998.
262. Nezo M, Miura Y, Noshiro T, Inoue M: Primary aldosteronism as a cause of severe postpartum hypertension in two women. Am J Obstet Gynecol 182: 745, 2000.
263. Murakami T, Ogura EW, Tanaka Y, Yamamoto M: High blood pressure lowered by pregnancy. Lancet 356: 1980, 2000.
264. Freier DT, Thompson NW: Pheochromocytoma and pregnancy: The epitome of high risk. Surgery 114: 1148, 1993.
265. Levin N, McTighe A, Abdel-Aziz MIE. Extra-adrenal pheochromocytoma in pregnancy. Maryland State Med J 32: 377, 1983.
266. Oishi S, Sato T: Pheochromocytoma in pregnancy: a review of the Japanese literature. Endocrine J 41: 219, 1994.
267. Lau P, Permezel M, Dawson P, et al. Phaeochromocytoma in pregnancy. Aust N Z J Obstet Gynaecol 36: 472, 1996.
268. Saarikoski S: Fate of noradrenaline in the human fetoplacental unit. Acta Physiol Scand 421 (Suppl): 1, 1974.
269. Dahia PLM, Hayashida CY, Strunz C, Abelin N, Toledo SPA: Low cord blood levels of catecholamine from a newborn of a pheochromocytoma patient. Eur J Endocrinol 130: 217, 1994.
270. Barzel US, Barlian Z, Runmery G, et al: Pheochromocytoma and pregnancy. Am J Obstet Gynecol 89: 519, 1964.
271. Bakri YN, Ingemansson SE, Ali A, Parikh S: Pheochromocytoma and pregnancy: Report of three cases. Acta Obstet Gynecol Scand 71: 301, 1992.
272. Harper MA, Murnaghan GA, Kennedy L, Hadden DR, Atkinson AB: Phaeochromocytoma in pregnancy: Five cases and a review of the literature. Br J Obstet Gynaecol 96: 594, 1989.
273. Combs CA, Easterling TR, Schmucker BC: Hemodynamic observations during paroxysmal hypertension in a pregnancy with pheochromocytoma. Obstet Gynecol 74: 439, 1989.
274. Falterman CJ, Kreisberg R: Pheochromocytoma: Clinical diagnosis and management. South Med J 75: 321, 1982.
275. Kalff V, Shapiro B, Lloyd R, et al: The spectrum of pheochromocytoma in hypertensive patients with neurofibromatosis. Arch Intern Med 142: 2092, 1982.
276. Kothari A, Bethune M, Manwaring J, Astley N, Wallace E: Massive bilateral phaeochromocytomas in association with von Hippel Lindau syndrome in pregnancy. Aust NZ J Obstet Gynaecol 39: 381, 1999.
277. Freier DT, Eckhauser FE, Harrison TS: Pheochromocytoma. Arch Surg 115: 388, 1980.
278. Sheps SG, Jiang NS, Klee GC: Diagnostic evaluation of pheochromocytoma. Endocrinol Metab Clin North Am 17: 397, 1988.
279. Pederson EB, Rasmussen AB, Christensen NJ, et al: Plasma noradrenaline and adrenaline in pre-eclampsia, essential hypertension in pregnancy and normotensive pregnant control subjects. Acta Endocrinol (Copenh) 99: 594, 1982.
280. Moodley J, McFadyen ML, Dilraj A, Rangiah S. Plasma noradrenaline and adrenaline levels in eclampsia. S Afr Med J 80: 191, 1991.
281. Santeiro ML, Stromquist C, Wyble L: Phenoxybenzamine placental transfer during the third trimester. Ann Pharmacother 30: 1249, 1996.
282. Lyons CW, Colmorgen GHC: Medical management of pheochromocytoma in pregnancy. Obstet Gynecol 72: 450, 1988.
283. Ahlawat SK, Jain S, Kumari S, Varma S, Sharma BK: Pheochromocytoma associated with pregnancy: Case report and review of the literature. Obstet Gynecol Surv 54: 728, 1999.
284. Devoe LD, O'Dell BE, Castillo RA, Hadi HA, Searle N: Metastatic pheochromocytoma in pregnancy and fetal biophysical assessment after maternal administration of alpha-adrenergic, beta-adrenergic, and dopamine antagonists. Obstet Gynecol 68 (Suppl 3): 15S, 1986.
285. Chatterjee TK, Parekh U: Phaeochromocytoma in pregnancy. Aust NZ J Obstet Gynaecol 25: 290, 1985.
286. Finkenstedt G, Gasser RW, Hofle G, et al: Pheochromocytoma and sub-clinical Cushing's syndrome during pregnancy: Diagnosis, medical pre-treatment and cure by laparoscopic unilateral adrenalectomy. J Endocrinol Invest 22: 551, 1999.
287. Schenker JG, Granat M: Phaeochromocytoma and pregnancy-An updated appraisal. Aust NZ J Obstet Gynaecol 22: 1, 1982.
288. Schenker JG, Chowers I: Pheochromocytoma and pregnancy: Review of 89 cases. Obstet Gynecol Surv 26: 739, 1971.
289. Galtier-Dereure F, Boegner C, Bringer J: Obesity and pregnancy: complications and cost. Am J Clin Nutr 71: 1242S, 2000.
290. Baeten JM, Bukusi EA, Lambe M: Pregnancy complications and outcomes among overweight and obese nulliparous women. Am J Publ Health 91: 436, 2001.
291. Kumari AS: Pregnancy outcome in women with morbid obesity. Int J Gynecol Obstet 73: 101, 2001.
292. Calandra C, Abell DA, Beischer NA. Maternal obesity in pregnancy. Obstet Gynecol 57: 8, 1981.
293. Edwards LE, Dickes WF, Alton IR, et al. Pregnancy in the massively obese. Course, outcome, and obesity prognosis of the infant. Am J Obstet Gynecol 1978;131: 479, 1978.
294. Garbaciak JA, Richter M, Miller S, et al. Maternal weight and pregnancy complications. Am J Obstet Gynecol 152: 238, 1985.
295. Vaughan RW, Engelhardt RC, Wise L. Postoperative hypoxemia in obese patients. Ann Surg 180: 877, 1976.
296. Maasilta P, Bachour A, Teramo K, Polo O, Laitinen LA: Sleep-related disordered breathing during pregnancy in obese women. Chest 120: 1448, 2001.
297. Stephansson O, Dickman PW, Johansson A, Cnattingius S: Maternal weight, pregnancy weight gain, and the risk for antepartum stillbirth. Am J Obstet Gynecol 184: 463, 2001.
298. Hendricks KA, Nuno OM, Suarez L, Larsen R: Effects of hyperinsulinemia and obesity on risk of neural tube defects among Mexican Americans. Epidemiol 12: 630, 2001.
299. Watkins ML, Botto LD: Maternal prepregnancy weight and congenital heart defects in the offspring. Epidemiol 11: 439, 2001.
300. Subcommittee on Nutritional Status and Weight Gain During Pregnancy, Food and Nutrition Board, Institute of Medicine: Nutrition During Pregnancy, pp 10-13. National Academy Press, Washington, D. C. , 1990.
301. Kliegman RM, Gross T. Perinatal problems of the obese mother and her infant. Obstet Gynecol 66: 299, 1985.
302. Gunderson EP, Abrams B: Epidemiology of gestational weight gain and body weight changes after pregnancy. Epidemiol Rev 22: 261, 2000.
303. Catalano PM, Tyzbir ED, Wolfe RR, et al: Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes. Am J Physiol 264: E60, 1993.
304. Freinkel N, Metzger BE, Nitzan M, et al: Facilitated anabolism in late pregnancy: Some novel maternal compensations for accelerated starvation. In Malaise WJ, Pirart J (eds): Proceedings of the VIIIth Congress of the International Diabetes Foundation, pp 474-488. Excerpta Medica International Congress Series No. 312, Amsterdam, 1974.
305. Persson B, Lunnel NO: Metabolic control in diabetic pregnancy. Variations in plasma concentrations of glucose, free fatty acids, glycerol, ketone bodies, insulin and human chorionic somatomammotropin during the last trimester. Am J Obstet Gynecol 122: 737, 1975.
306. Metzger BE, Phelps RL, Freinkel N, et al: Effects of gestational diabetes on diurnal profiles of plasma glucose, lipids and individual amino acids. Diabetes Care 3: 402, 1980.
307. Freinkel N: The Banting Lecture 1980: Of Pregnancy and progeny. Diabetes 29: 1023, 1980.
308. Freinkel N, Metzger BE: Pregnancy as a tissue culture experience: The critical implications of maternal metabolism for fetal development. In Pregnancy Metabolism, Diabetes and the Fetus (CIBA Foundation Symposium No. 63), pp 3-23. Exerpta Medica, Amsterdam, 1979.
309. Mills JL, Baker L, Goldman AS: Malformations in infants of diabetic mothers occur before the seventh gestational week: Implications for treatment. Diabetes 28: 292, 1979.
310. Pedersen J: The Pregnant Diabetic and Her Newborn: Problems and Management. Williams & Wilkins, Baltimore, 1977.
311. Ray JG, O'Brien TE, Chan WS: Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis. QJM 94: 435, 2001.
312. Greene MF, Hare JW, Cloherty JP, et al: First trimester hemoglobin A1 and risk for major malformations and spontaneous abortion in diabetic pregnancy. Teratology 39: 225, 1989.
313. Mills JL, Knopp RH, Simpson JL, et al: Lack of relation of increased malformation rates in infants of diabetic mothers to glycemic control during organogenesis. N Engl J Med 318: 671, 1988.
314. Kitzmiller JL, Gavin LA, Gin GD, et al: Preconception care of diabetes. Glycemic control prevents congenital anomalies. JAMA 265: 731, 1991.
315. Damm P, Molsted-Pedersen L: Significant decrease in congenital malformations in newborn infants of an unselected population of diabetic women. Am J Obstet Gynecol 161: 1163, 1989.
316. Naeye RL: Infants of diabetic mothers: A quantitative, morphologic study. Pediatrics 35: 980, 1965.
317. Whitelaw A: Subcutaneous fat in newborn infants of diabetic mothers: An indication of quality of diabetic control. Lancet 1: 15, 1977.
318. Metzger BE: Biphasic effects of maternal metabolism on fetal growth: The quintessential expression of "fuel-mediated teratogenesis. " Diabetes 40 (Suppl 2): 99, 1991.
319. Reiher H, Fuhrmann K, Noack S, et al: Age-dependent insulin secretion of the endocrine pancreas in vitro from fetuses of diabetic and nondiabetic patients. Diabetes Care 6: 446, 1983.
320. Weiss PAM, Scholz HS, Haas J, Tamussino KF: Effect of fetal hyperinsulinism on oral glucose tolerance test results in patients with gestational diabetes mellitus. Am J Obstet Gynecol 184: 470, 2001.
321. Neiger R: Fetal macrosomia in the diabetic patient. Clin Obstet Gynecol 35: 138, 1992.
322. Silverman BL, Purdy LP, Metzger BE: The intrauterine environment: Implications for the offspring of diabetic mothers. Diabetes Rev 4: 21, 1996.
323. Pettitt DJ, Baird HR, Aleck KA, et al: Excessive obesity in offspring of Pima Indian women with diabetes during pregnancy. N Engl J Med 308: 242, 1983.
324. Pettitt DJ, Knowler WC, Bennett PH, et al: Obesity in offspring of diabetic Pima Indian women despite normal birth weight. Diabetes Care 10: 76, 1987.
325. Silverman BL, Rizzo T, Green OC, et al: Long-term prospective evaluation of offspring of diabetic mothers. Diabetes 40 (Suppl 2): 121, 1991.
326. Pettitt DJ, Aleck KA, Baird HR, et al: Congenital susceptibility for NIDDM: Role of intrauterine environment. Diabetes 37: 622, 1988.
327. Silverman BL, Cho NH, Metzger BE: Impaired glucose tolerance in adolescent offspring of diabetic mothers: Relationship to fetal hyperinsulinism. Diabetes Care 18: 611, 1995.
328. Harris MI, Flegal KM, Cowie CC, et al: Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U. S. adults: The third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 21: 518, 1998.
329. Connell FA, Vadheim, Emanuel I: Diabetes in pregnancy: a population based study of incidence, referral for care and perinatal mortality. Am J Obstet Gynecol 151: 598, 1985.
330. Dooley SL, Metzger BE, Cho NH: Gestational diabetes mellitus: Influence of race on disease prevalence and perinatal outcomes in a U. S. population. Diabetes 40 (Suppl 2): 25, 1991.
331. Metzger BE, Cho NH: Epidemiology and genetics. In Reece EA, Coustan DR (eds. ): Diabetes Mellitus in Pregnancy, 2nd ed. , pp 11-26. Churchill Livingstone, New York, 1995.
332. Buchanan TA, Metzger BE, Freinkel N, et al: Insulin sensitivity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. Am J Obstet Gynecol 162: 1008, 1990.
333. Kautzky-Willer A, Prager R, Waldhausl W, et al: Pronounced insulin resistance and inadequate b-cell secretion characterize lean gestational diabetes during and after pregnancy. Diabetes Care 20: 1717, 1997.
334. Metzger BE, Coustan DR, and the Organizing Committee: Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 21 (Suppl 2): B161, 1998.
335. American Diabetes Association: Position statement: gestational diabetes mellitus. Diabetes Care 24 (Suppl 1): S77, 2001.
336. Carr S, Coustan DR, Martelly P, et al: Precision of reflectance meters in screening for gestational diabetes. Obstet Gynecol 73: 727, 1989.
337. O'Sullivan JB, Mahan CM: Criteria for the oral glucose tolerance test in pregnancy. Diabetes 13: 278, 1964.
338. Magee MS, Walden CE, Benedetti TJ, et al: Influence of diagnostic criteria on the incidence of gestational diabetes and perinatal morbidity. JAMA 269: 609, 1993.
339. Berkus MD, Langer O, Piper JM, Luther MF: Efficiency of lower threshold criteria for the diagnosis of gestational diabetes. Obstet Gynecol 86: 892, 1995.
340. Rust OA, Bofill JA, Andrew ME, et al: Lowering the threshold for the diagnosis of gestational diabetes. Am J Obstet Gynecol 175: 961, 1996.
341. Phelps RL, Sakol P, Metzger BE, et al: Changes in diabetic retinopathy during pregnancy: Correlations with regulation of hyperglycemia. Arch Ophthalmol 104: 1806, 1986.
342. Rosenn B, Miodovnik M, Kranias G, et al: Progression of diabetic retinopathy in pregnancy: Association with hypertension in pregnancy. Am J Obstet Gynecol 166: 1214, 1992.
343. The Diabetes Control and Complications Trial Research Group: Effect of pregnancy on microvascular complications in the diabetes control and complications trial. Diabetes Care 24: 794, 2001.
344. Chen HC, Newsom RSB, Patel V, et al: Retinal blood flow changes during pregnancy in women with diabetes. Invest Ophthalmol Vis Sci 35: 3199, 1994.
345. Hill DJ, Flyvbjerg A, Arany E, et al: Increased levels of serum fibroblast growth factor-2 in diabetic pregnant women with retinopathy. J Clin Endocrinol Metab 82: 1452, 1997.
346. Conway M, Baldwin J, Kohner EM, et al: Postpartum progression of diabetic retinopathy. Diabetes Care 14: 1110, 1991.
347. Siddiqi T, Rosenn B, Mimouni F, Khoury J, Miodovnik M: Hypertension during pregnancy in insulin-dependent diabetic women. Obstet Gynecol 77: 514, 1991.
348. Kitzmiller JL, Brown ER, Phillippe M, et al: Diabetic nephropathy and perinatal outcome. Am J Obstet Gynecol 141: 741, 1981.
349. Reece EA, Coustan DR, Hayslett JP, et al: Diabetic nephropathy: pregnancy performance and fetomaternal outcome. Am J Obstet Gynecol 159: 56, 1988.
350. Biesenbach G, Stoeger H, Zazgornik J: Influence of pregnancy on progression of diabetic nephropathy and subsequent requirement of renal replacement therapy in female type I diabetic patients with impaired renal function. Nephrol Dial Transplant 1992; 7: 105, 1992.
351. Purdy LP, Hantsch CE, Molitch ME, et al: Effect of pregnancy on renal function in patients with moderate-to-severe diabetic renal insufficiency. Diabetes Care 19: 1067, 1996.
352. Macleod AF, Smith SA, Sonksen PH, Lowy C: The problem of autonomic neuropathy in diabetic pregnancy. Diabetic Med 7: 80, 1990.
353. Airaksinen KEJ, Anttila LM, Linnaluoto MK, et al: Autonomic influence on pregnancy outcome in IDDM. Diabetes Care 13: 756, 1990.
354. Scott AR, Tattersall RB, McPherson M: Improvement of postural hypotension and severe diabetic autonomic neuropathy during pregnancy. Diabetes Care 11: 369, 1988.
355. Siddiqi T, Rosenn B, Mimouni F, et al: Hypertension during pregnancy in insulin-dependent diabetic women. Obstet Gynecol 77: 514, 1991.
356. Cousins L: Pregnancy complications among diabetic women: Review 1965-1985. Obstet Gynecol Surv 42: 140, 1987.
357. Ueland K, Metcalfe J: Circulatory changes in pregnancy. Clin Obstet Gynecol 18: 41, 1975.
358. Rosenn BM, Miodovnik M, Holcberg G, et al: Hypoglycemia: The price of intensive insulin therapy in insulin-dependent diabetes mellitus pregnancies. Obstet Gynecol 85: 417, 1995.
359. Jovanovic-Peterson L, Peterson CM, Reed GF, et al: Maternal postprandial glucose levels and infant birth weight: The Diabetes in Early Pregnancy Study. Am J Obstet Gynecol 1991; 164: 103, 1991.
360. Buchanan TA, Metzger BE, Freinkel N: Accelerated starvation in late pregnancy: A comparison between obese women with and without gestational diabetes mellitus. Am J Obstet Gynecol 162: 1015, 1990.
361. Peterson CM, Jovanovic-Peterson L: Percentage of carbohydrate and glycemic response to breakfast, lunch and dinner in women with gestational diabetes. Diabetes 40 (Suppl 2): 172, 1991.
362. Koukkou E, Ghosh P, Lowy C, Poston L: Offspring of normal and diabetic rats fed saturated fat in pregnancy demonstrate vascular dysfunction. Circulation 98: 2899, 1998.
363. Ghosh P, Bitsanis D, Ghebremeskel K, Crawford MA, Poston L: Abnormal aortic fatty acid composition and small artery function in offspring of rats fed a high fat diet in pregnancy. J Physiol 533: 815, 2001.
364. Coustan DR, Imarah J: Prophylactic insulin treatment of gestational diabetes reduces the incidence of macrosomia, operative delivery and birth trauma. Am J Obstet Gynecol 150: 836, 1984.
365. Landon MB, Sonek J, Foy P, et al: Sonographic measurement of fetal humeral soft tissue thickness in pregnancy complicated by GDM. Diabetes 40 (Suppl 2): 66, 1991.
366. Bochner CJ, Medearis AL, Williams J, et al: Early third trimester ultrasound screening in gestational diabetes to determine the risk of macrosomia and labor dystocia at term. Am J Obstet Gynecol 157: 703, 1987.
367. Kjos SL, Schaefer-Graf U, Sardesi S, et al: A randomized controlled trial using glycemic plus fetal ultrasound parameters versus glycemic parameters to determine insulin therapy in gestational diabetes with fasting hyperglycemia. Diabetes Care 24: 1904, 2001.
368. Jovanovic-Peterson L, Durak EP, Peterson CM: Randomized trial of diet versus diet plus cardiovascular conditioning on glucose levels in gestational diabetes. Am J Obstet Gynecol 161: 415, 1989.
369. Bung P, Artal R, Khodiguian N, et al: Exercise in gestational diabetes: An optimal therapeutic approach? Diabetes 40 (Suppl 2): 182, 1991.
370. Revelli A, Durando A, Massobrio M: Exercise and pregnancy: A review of maternal and fetal effects. Obstet Gynecol Surv 47: 355, 1992.
371. Hellmuth E, Damm P, Molsted-Pedersen L: Congenital malformations in offspring of diabetic women treated with oral hypoglycaemic agents during embryogenesis. Diabetic Med 11: 471, 1994.
372. Piacquadio K, Hollingsworth DR, Murphy H: Effects of in-utero exposure to oral hypoglycaemic drugs. Lancet 338: 866, 1991.
373. Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O: A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 343: 1134, 2000.
374. Caplan RH, Pagliara AS, Beguin EA, et al: Constant intravenous insulin infusion during labor and delivery in diabetes mellitus. Diabetes Care 5: 6, 1982.
375. Haigh SE, Tevaarwerk GJM, Harding PEG, et al: A method for maintaining normoglycemia during labor and delivery in insulin-dependent diabetic women. Can Med Assoc J 126: 487, 1982.
376. Jovanovic L, Peterson CM: Insulin and glucose requirements during the first stage of labor in insulin-dependent diabetic women. Am J Med 75: 607, 1983.
377. Pettitt DJ, Forman MR, Hanson RL, Knowler WC, Bennett PH: Breastfeeding and incidence of non-insulin-dependent diabetes mellitus in Pima Indians. Lancet 350: 166, 1997.
378. Plagemann A, Harder T, Kohlhoff R: Long-term impact of neonatal breast-feeding on body weight and glucose tolerance in children of diabetic mothers. Diabetes Care 25: 16, 2002.
379. Metzger BE, Cho NH, Roston SM, et al: Prepregnancy weight and antepartum insulin secretion predict glucose tolerance five years after gestational diabetes mellitus. Diabetes Care 16: 1598, 1993.
380. Kjos SL, Peters RK, Xiang A, et al: Predicting future diabetes in Latino women with gestational diabetes: Utility of early postpartum glucose tolerance testing. Diabetes 44: 586, 1995.
381. Damm P, Kuhl C, Bertelsen A, et al: Predictive factors for the development of diabetes in women with previous gestational diabetes. Am J Obstet Gynecol 167: 607, 1992.
382. Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346: 393, 2002.
383. Buchanan TA, Xiang AH, Peters RK, et al: Protection from type 2 diabetes persists in the TRIPOD cohort eight months after stopping troglitazone. Diabetes 50 (Suppl 2): A81, 2001.
384. Clark Jr CM, Qiu C, Amerman B, et al: Gestational diabetes: should it be added to the syndrome of insulin resistance? Diabetes Care 20: 867, 1997.
385. Spong CY, Guillermo L, Kuboshige J, et al: Recurrence of gestational diabetes mellitus: identification of risk factors. Am J Perinatol 1998; 15: 29, 1998.
386. Moses RG, Shand JL, Tapsell LC: The recurrence of gestational diabetes: Could dietary differences in fat intake be an explanation? Diabetes Care 20: 1647, 1997.
387. Kjos SL: Contraception in diabetic women. Obstet Gynecol Clin N Am 23: 243, 1996.
388. Alvarez JJ, Montelongo A, Iglesias A, Lasuncion MA, Herrera E: Longitudinal study on lipoprotein profile, high density lipoprotein subclass, and postheparin lipases during gestation in women. J Lipid Res 37: 299, 1996.
389. Kitajima M, Oka S, Yasuhi I, Fukuda M, Rii Y, Ishimaru T: Maternal serum triglyceride at 24-32 weeks' gestation and newborn weight in nondiabetic women with positive diabetic screens. Obstet Gynecol 97: 776, 2001.
390. Chiang A-N, Yang M-L, Hung J-H, Chou P, Shyn S-K, Ng H-T: Alterations of serum lipid levels and their biological relevances during and after pregnancy. Life Sciences 56: 2367, 1995.
391. Knopp RH, Warth MR, Charles D, et al. Lipoprotein metabolism in pregnancy, fat transport to the fetus and the effects of diabetes. Biol Neonate 50: 297, 1986.
392. Butte NF: Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. Am J Clin Nutr 71(Suppl 1): 1256S, 2000.
393. De Arcos F, Castelo-Branco C, Casals E, Sanllehy C, Cararach V: Normal and gestational diabetic pregnancies: lipids, lipoproteins and apolipoproteins. J Reprod Med 43: 144, 1998.
394. Roberts IM. Hyperlipidemic gestational pancreatitis. Gastroenterology 104: 1560, 1993.
395. Jaber PW, Wilson BB, Johns DW, Cooper PH, Ferguson II JE: Eruptive xanthomas during pregnancy. J Am Acad Dermatol 27: 300, 1992.
396. Swoboda K, Derfler K, Koppensteiner R, et al: Extracorporeal lipid elimination for treatment of gestational hyperlipidemic pancreatitis. Gastroenterology 104: 1527, 1993.
397. Saravanan P, Blumenthal S, Anderson C, Stein R, Berkelhammer C: Plasma exchange for dramatic gestational hyperlipidemic pancreatitis. J Clin Gastroenterol 22: 295, 1996.
398. Kroon AA, Swinkels DW, van Dongen PWJ, Stalenhoef AFH: Pregnancy in a patient with homozygous familial hypercholesterolemia treated with long-term low-density lipoprotein apheresis. Metabolism 43: 1164, 1994.